ODDITY Tech Ltd.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Oran Holtzman
- Full Time Employees
- 658
- Sector
- Technology services
- Industry
- Packaged software
- Address
- 8 Haharash Street Tel Aviv Israel 6761304
- IPO Date
- Jul 19, 2023
- CIK
- 0001907085
- Website
- oddity.com
- Similar Companies
- Business
- Oddity Tech Ltd. (Nasdaq: ODD) operates as a consumer technology company that develops and scales digital-first brands in the beauty, wellness and medical telehealth industries through an AI-driven online platform leveraging data science, machine learning and computer vision. The company offers core products including foundation, concealer, lipstick, mascara, eye, brow and lip makeup; skincare and haircare treatments; supplements; and makeup tools under the IL MAKIAGE and SpoiledChild brands; alongside an expanding portfolio of medical-grade dermatology products such as creams, supplements and cosmetics addressing acne, hyperpigmentation and eczema via its new METHODIQ telehealth platform; with ODDITY LABS biotechnology center deploying AI-based molecule discovery for novel ingredients. Founded in 2013 and headquartered in Tel Aviv, Israel, with additional offices in New York City and a biotechnology lab in Boston, Oddity Tech serves consumers worldwide, primarily in the United States and internationally. Recent developments include the November 2025 launch of the METHODIQ brand and telehealth platform in partnership with board-certified dermatologists for AI-powered personalized skincare; the January 2025 acquisition of Fionic's AI intellectual property and elite research team to enhance predictive modeling and consumer engagement algorithms; and raised full-year 2025 revenue guidance to $806-$809 million reflecting 24-25% growth amid record Q3 results.
Company News
New Strong Buy Stocks for November 4th
New Strong Buy Stocks for October 29th
ODDITY to Announce Third Quarter 2026 Financial Results on November 11, 2026
Baillie Gifford Trims ODDITY Tech Ltd (ODD) Stake -- Shares Look 55% Undervalued on GF Value
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate NDA Resubmission and PDUFA Date of March 25, 2027
ImmunoForge to Showcase Proprietary Platform Technologies and Next-Generation Oncology & Phase 2 Clinical Pipelines at BIO-Europe 2026
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate NDA Resubmission and PDUFA Date of March 25, 2027
Oddity Tech (ODD) Upgraded to Strong Buy: Here's What You Should Know
New Strong Buy Stocks for October 15th
Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Granted Orphan Drug Designation in Japan, Further Expanding Global Regulatory Recognition
ODDITY Tech Ltd (ODD) Shares Fall 5.1% -- What GF Score of 71 Tells Investors
Earnings Estimates Moving Higher for Oddity Tech (ODD): Time to Buy?
Oddity Tech: Turnaround Potential And Discounted Debt Value Lever
Why Oddity Tech's Stock Skyrocketed 26.5% Today
Oddity Tech Ltd. (ODD) Q2 2026 Earnings Call Transcript
ODDITY shares surge on Q2 beat and raised FY26 guidance
ODDITY Tech Q2 Earnings Call Highlights
Oddity Tech (ODD) Beats Q2 Earnings and Revenue Estimates
ODDITY Tech Reports Second Quarter 2026 Results, Expects Sequential Revenue Improvement in the Third Quarter
Critical Comparison: ODDITY Tech (NASDAQ:ODD) versus Jamieson Wellness (OTCMKTS:JWLLF)